Dillon & Associates »

Regeneron Pharmaceuticals shares owned by Dillon & Associates

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Dillon & Associates from 13F filings

Historical chart of Dillon & Associates investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Dillon & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Dillon & Associates

Quarter filed Position value Share count Share price at filing
2024-03-31 $12M 12k 962.00
2023-12-31 $10M 12k 878.00
2023-09-30 $10M 12k 823.00
2023-06-30 $8.5M 12k 719.03
2023-03-31 $8.9M 11k 821.96
2022-12-31 $7.6M 11k 721.05
2022-09-30 $7.3M 11k 688.96
2022-06-30 $6.0M 10k 590.96
2022-03-31 $6.8M 9.7k 698.04
2021-12-31 $5.8M 9.2k 632.02
2021-09-30 $4.8M 7.9k 605.02
2021-06-30 $3.6M 6.4k 559.01
2021-03-31 $1.7M 3.5k 473.00